收费全文 | 5779713篇 |
免费 | 426955篇 |
国内免费 | 18247篇 |
耳鼻咽喉 | 80960篇 |
儿科学 | 183725篇 |
妇产科学 | 153070篇 |
基础医学 | 847523篇 |
口腔科学 | 163257篇 |
临床医学 | 537831篇 |
内科学 | 1055151篇 |
皮肤病学 | 134588篇 |
神经病学 | 476754篇 |
特种医学 | 224912篇 |
外国民族医学 | 1177篇 |
外科学 | 858526篇 |
综合类 | 160818篇 |
现状与发展 | 30篇 |
一般理论 | 3212篇 |
预防医学 | 478995篇 |
眼科学 | 139311篇 |
药学 | 415705篇 |
28篇 | |
中国医学 | 16365篇 |
肿瘤学 | 292977篇 |
2021年 | 62382篇 |
2019年 | 63230篇 |
2018年 | 82763篇 |
2017年 | 63382篇 |
2016年 | 71179篇 |
2015年 | 83864篇 |
2014年 | 119568篇 |
2013年 | 187207篇 |
2012年 | 177530篇 |
2011年 | 190090篇 |
2010年 | 145728篇 |
2009年 | 141723篇 |
2008年 | 171321篇 |
2007年 | 184832篇 |
2006年 | 189494篇 |
2005年 | 183105篇 |
2004年 | 181964篇 |
2003年 | 169803篇 |
2002年 | 157527篇 |
2001年 | 231895篇 |
2000年 | 230009篇 |
1999年 | 203293篇 |
1998年 | 81516篇 |
1997年 | 74345篇 |
1996年 | 72218篇 |
1995年 | 67741篇 |
1994年 | 61544篇 |
1993年 | 56919篇 |
1992年 | 151134篇 |
1991年 | 145748篇 |
1990年 | 140847篇 |
1989年 | 136697篇 |
1988年 | 125970篇 |
1987年 | 123695篇 |
1986年 | 116901篇 |
1985年 | 113491篇 |
1984年 | 90294篇 |
1983年 | 78952篇 |
1982年 | 56054篇 |
1981年 | 51522篇 |
1980年 | 48272篇 |
1979年 | 79838篇 |
1978年 | 60944篇 |
1977年 | 53387篇 |
1976年 | 49706篇 |
1975年 | 51301篇 |
1974年 | 58289篇 |
1973年 | 56077篇 |
1972年 | 52582篇 |
1971年 | 48701篇 |
Design: A mixed-methods design, applying the Schwartz and Sprangers response shift (RS) model. RS is a cognitive process wherein, in response to a change in health status, individuals change internal standards, values, or conceptualization of QOL
Setting: Community-dwelling participants who receive medical treatment at a major Midwestern medical system and nearby Veterans’ Affairs hospital.
Participants: A purposive sample of participants with SCI (N?=?40) completed semi-structured interviews and accompanying quantitative measures.
Interventions: Not applicable.
Outcome Measures: Qualitative data were analyzed using content analysis to identify themes. Analysis of variance were performed to detect differences based on themes and QOL, well-being, and demographic and injury characteristics.
Results: Four RS themes were identified, capturing the range of participant perceptions of QOL. The themes ranged from complete RS, indicating active engagement in maintaining QOL, to awareness and comparisons redefining QOL, to a relative lack of RS. Average QOL ratings differed as a function of response shift themes. PROMIS Global Health, Anxiety, and Depression also differed as a function of RS themes.
Conclusion: The RS model contextualizes differences in QOL definitions, appraisals, and adaptations in a way standardized QOL measures alone do not. 相似文献
Purpose
New instrument-based techniques for anterior chamber (AC) cell counting can offer automation and objectivity above clinician assessment. This review aims to identify such instruments and its correlation with clinician estimates. 相似文献Areas covered: This review provides an overview of existing pharmacotherapy for osteoporosis in women and explore state-of–the-art and emerging therapies to prevent bone loss, with an emphasis on the mechanism of action, indications and side effects.
Expert opinion: Bisphosphonates appear to be a reliable and cost-effective option, whereas denosumab has introduced a simpler dosing regimen and may achieve a linear increase in bone mineral density (BMD) with no plateau being observed, along with continuous anti-fracture efficacy. Abaloparatide, a parathyroid-hormone-related peptide (PTHrP)-analogue, approved by the FDA in April 2017, constitutes the first new anabolic osteoporosis drug in the US for nearly 15 years and has also proven its anti-fracture efficacy. Romosozumab, a sclerostin inhibitor, which induces bone formation and suppresses bone resorption, has also been developed and shown a significant reduction in fracture incidence; however, concerns have arisen with regard to increased cardiovascular risk. 相似文献